Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass

Noa P Yee1, Andrea M Siu1, James Davis1

  • 1Undergraduate, Tufts University, Medford, MA.

Insights

Coronary artery bypass grafting (CABG) showed greater left ventricular (LV) function recovery than percutaneous coronary intervention (PCI) in patients with severely reduced LV ejection fraction (LVEF) and multivessel coronary artery disease (CAD). CABG may be preferred.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Left ventricular (LV) function recovery after revascularization is documented for coronary artery bypass grafting (CABG).
  • LV function recovery following percutaneous coronary intervention (PCI) and its comparison to CABG is less understood.
  • Severely reduced LV function in multivessel coronary artery disease (CAD) presents a critical clinical scenario.

Purpose of the Study:

  • To compare LV function recovery between PCI and CABG in patients with severely reduced LV ejection fraction (LVEF) and multivessel CAD.
  • To evaluate the long-term efficacy of PCI versus CABG in improving LVEF in this patient cohort.

Main Methods:

  • Single-center retrospective study including 192 patients (16 CABG, 176 PCI) with LVEF < 40% and multivessel CAD.
  • Analysis of LVEF at baseline, 6 months, and 12 months post-revascularization.
  • Statistical comparison of LVEF changes between the PCI and CABG groups.

Main Results:

  • Baseline LVEF differed significantly between groups (PCI: 28.5 ± 8.0 vs. CABG: 24.2 ± 6.8, P=.05).
  • No significant difference in LVEF recovery was observed at 6 months.
  • At 12 months, CABG demonstrated significantly greater LVEF recovery (15.25) compared to PCI (4.82) (P=.005).

Conclusions:

  • Both PCI and CABG lead to statistically significant LVEF improvement over time in patients with severely reduced LV function and multivessel CAD.
  • Coronary artery bypass grafting (CABG) is associated with superior LVEF recovery compared to percutaneous coronary intervention (PCI) at one-year follow-up.
  • CABG may be the preferred revascularization strategy for patients with depressed LV function and multivessel coronary artery disease.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
991